PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-47.60%
Both yoy net incomes decline, with JHX at -61.99%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
9.21%
D&A growth well above JHX's 3.47%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-2468.04%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-11.59%
Both cut yoy SBC, with JHX at -6.10%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
479.04%
Slight usage while JHX is negative at -206.49%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
1000.64%
AR growth while JHX is negative at -207.16%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-237.69%
Both reduce yoy inventory, with JHX at -15.82%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
74.75%
Some yoy usage while JHX is negative at -199.44%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
349.64%
Well above JHX's 692.44%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
83.71%
Some CFO growth while JHX is negative at -42.79%. John Neff would note a short-term liquidity lead over the competitor.
-76.27%
Both yoy lines negative, with JHX at -24.91%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
96.49%
Less M&A spending yoy vs. JHX's 343.62%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-57.14%
Negative yoy purchasing while JHX stands at 12.31%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-4376.19%
We reduce yoy other investing while JHX is 3250.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1.85%
Both yoy lines negative, with JHX at -24.49%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
771.60%
Debt repayment above 1.5x JHX's 98.61%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
1071.60%
We slightly raise equity while JHX is negative at -1.18%. John Neff sees competitor possibly preserving share count or buying back shares.
18.61%
We have some buyback growth while JHX is negative at -0.13%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.